Published on 5 April 2022
Description:
How patients and HCPs are powering a new era of launch excellence; Tackling life sciences disputes; Clinical trials and the patient perspective
Categories:
Pharmaceutical Market EuropePreview:
32 articles from this collection:
PME April 2022
2 - M3
3 - Comment
4 - T40
5 - Contents
6-7 - News
6-7 - PME - Pharma Market Europe Pharmaceutical News
8-9 - News
10-11 - Coronavirus news
12 - DARWIN'S MEDICINE - Holistic excellence
12 - Pharma Market Europe Darwin’s medicine
13 - POLICY AND PUBLIC HEALTH - A zero-sum game
The technology responses to this pandemic have fallen far short of expectations
14 - MIKE DIXON - Following the trend
15 - PHARMA MARKETERS’ BLOG - Reducing the ‘friction’ with a customer experience strategy
16-17 - LIFE SCIENCES - Now the face masks and gloves are off
18 - THOUGHT LEADER EDELMAN - Virtually present
19 - TL ICON CLINICAL - The decentralisation of clinical trials is a key catalyst for innovation in artificial intelligence
20 - COMMUNIQUE AWARDS 2022
21 - TL ICON DIVERSITY- Equipping our people leaders to drive an inclusive organisation
22-23 - Clinical trials and the patient’s perspective
24 - APRIL Highlights
25 - TL TCEG - The great reset of frontline HCP relationships
26-28 - Listen, learn and lift off
29 - TL LUCID - Launch excellence
30 - TL PURPLE AGENCY - Let them eat peanut butter on toast
31 - TL VISFO - Is there such a thing as the new normal?
32-34 - STRATEGY - Lessons from a pandemic
35 - EBR
36-37 - BRAND PLANNING - Brand planning in a COVID-19 world
38-40 - Appointments
41 - HEALTHCARE COMMS
42 - Q&A - Julia Kirby
43 - Recruitment
43 - Pharma Market Europe (PME) Recruitment
44 - NUCLEUS GLOBAL
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services